ArticleJournal of acquired immune deficiency syndromes (1999)2016

Rilpivirine and Doravirine Have Complementary Efficacies Against NNRTI-Resistant HIV-1 Mutants.

Steven J Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.